# Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo

> **NCT04531033** · NA · COMPLETED · sponsor: **Lemuel W. Taylor IV** · enrollment: 50 (actual)

## Conditions studied

- Lactose Intolerance

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus acidophilus MPH734
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04531033
- **Lead sponsor:** Lemuel W. Taylor IV
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-25
- **Primary completion:** 2021-08-25
- **Final completion:** 2022-11-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531033, "Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04531033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*